|
|
Article: ORNL, Georgia's Isotron develop promising new cancer treatment.
- Article from:
- Biotech Week
- Article date:
- February 19, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 FEB 19 - (NewsRx.com & NewsRx.net) -- Doctors treating incurable brain tumors and other cancers resistant to conventional therapies will soon have a new treatment available to them because of a development by Isotron of Alpharetta, Georgia, and the Department of Energy's Oak Ridge National Laboratory (ORNL).
The advantage of the treatment, called neutron brachytherapy, is that physicians can deliver a highly concentrated dose of californium-252 neutrons to the site of a tumor instead of having to treat the tumor with conventional gamma rays, which often are not as effective. This therapy has proved particularly useful against cancers that are resistant to ...